SEC lauds cooperators, whistleblowers in FY23 enforcement results
By 
Kyle Brasseur2023-11-15T15:46:00
A big year for disgorgement helped the Securities and Exchange Commission (SEC) to its second highest total of financial remedies ordered in a single year in fiscal year 2023.
The agency’s FY23 enforcement results, released Tuesday, noted it obtained orders for nearly $5 billion in financial remedies during the year, which ended Sept. 30. The total fell short of the record $6.4 billion in enforcement penalties, fees, and interest the SEC collected in FY22.
Unlike FY22’s totals, which were driven largely by a record $4.2 billion in civil penalties, the SEC relied more on disgorgement and prejudgment interest for its enforcement success in FY23. Financial remedies comprised nearly $3.4 billion in disgorgement and prejudgment interest and nearly $1.6 billion in civil penalties, both the second highest amounts on record.
Related articles
-
PremiumSEC’s Grewal shares views on ‘Five Principles of Effective Cooperation’
Gurbir Grewal, director of the Enforcement Division at the Securities and Exchange Commission, spelled out plainly his view on the best path to earning cooperation credit during settlement negotiations with the agency.
-
News BriefJPMorgan to pay record $18M for violating SEC whistleblower rule
A subsidiary of JPMorgan Chase will pay an $18 million fine to the Securities and Exchange Commission for allegedly violating the agency’s whistleblower protection rule in hundreds of settlement agreements with clients and customers.
-
PodcastDigital Transformation of Compliance podcast: GWU Professor Kyle Welch
In this episode of the Digital Transformation of Compliance podcast series, Kyle Welch, a George Washington University associate professor of accountancy, discusses findings from his research on internal whistleblowing and compliance dashboards built by publicly traded U.S. companies to leverage hotline data.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”